Identification of interferon-stimulated genes with modulated expression during hepatitis E virus infection in pig liver tissues and human HepaRG cells

Front Immunol. 2023 Nov 20:14:1291186. doi: 10.3389/fimmu.2023.1291186. eCollection 2023.

Abstract

Introduction: Hepatitis E virus (HEV) is a common cause of enterically transmitted acute hepatitis worldwide. The virus is transmitted by the fecal-oral route via the consumption of contaminated water supplies and is also a zoonotic foodborne pathogen. Swine are the main reservoir of zoonotic HEV. In humans, HEV infection is usually asymptomatic or causes acute hepatitis that is self-limited. However, fulminant hepatic failure and chronic cases of HEV infection can occur in some patients. In contrast, HEV infection in pigs remains asymptomatic, although the virus replicates efficiently, suggesting that swine are able to control the virus pathogenesis. Upon viral infection, IFN is secreted and activates cellular pathways leading to the expression of many IFN-stimulated genes (ISGs). ISGs can restrict the replication of specific viruses and establish an antiviral state within infected and neighboring cells.

Methods: In this study, we used PCR arrays to determine the expression level of up to 168 ISGs and other IFN-related genes in the liver tissues of pigs infected with zoonotic HEV-3c and HEV-3f and in human bipotent liver HepaRG cells persistently infected with HEV-3f.

Results and discussion: The expression of 12 and 25 ISGs was found to be up-regulated in infected swine livers and HepaRG cells, respectively. The expression of CXCL10, IFIT2, MX2, OASL and OAS2 was up-regulated in both species. Increased expression of IFI16 mRNA was also found in swine liver tissues. This study contributes to the identification of potential ISGs that could play a role in the control or persistence of HEV infection.

Keywords: IFN-stimulated gene (ISG); antiviral response; hepatitis E virus (HEV); interferon (IFN); zoonosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Hepatitis E virus* / genetics
  • Hepatitis E* / genetics
  • Hepatocytes
  • Humans
  • Interferons / genetics
  • Swine

Substances

  • Interferons

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was funded by the Agence Nationale de la Recherche (HEVISTAR project, grant ANR-16-CE35-0002-01) and the Agence Nationale de la Recherche sur le SIDA et les hépatites virales - Maladies Infectieuses Emergentes (ANRS-MIE) (AAP2022-1, grant ECTZ187893). SG is supported by a post-doctoral research grant from ANRS-MIE (AAP2022-1, grant ECTZ187635).